AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.

Slides:



Advertisements
Similar presentations
Catecholamine Agonists and Antagonists. Need-to-know Drugs Norepinephrine Norepinephrine Alpha 1 & 2 and Beta 1 agonist Alpha 1 & 2 and Beta 1 agonist.
Advertisements

Sympathetic Drugs. Stress and The Adrenal Glands.
PHARMACOLOGY OF SNS.
Pharmacology II The Autonomic Nervous System Adrenergic antagonists
Adrenergic agonists Samuel Aguazim (MD).
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 17 Adrenergic Agonists.
Autonomic Nervous System Drugs
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Adrenergic Blockers Asmah Nasser, M.D..
Adrenoceptor Blockers
Drugs Affecting the Sympathetic Nervous System
ADRENERGIC ANTAGONITS
Adrenergic Antagonists. These drugs act by either reversibly or irreversibly attaching to the receptor, thus preventing its activation by endogenous catecholamines.
Adrenergic antagonist sympatholytic
ADRENERGIC MEDICATIONS (sympathomimetic drugs) BY:DR.ISRAA OMAR.
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Sympathomimetics (continue)
SYMPATHOMIMETICS Classification: A- According to the source:
Adrenergic agonists Samuel Aguazim (MD).
ANTI-ADRENERGIC DRUGS
AUTONOMIC SYSTEMS AND DRUGS-2
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
Autonomic drugs: Adrenoceptor Agonists and Sympathomimetics
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
Synthesis & Release of Neurotransmitters
1 Adrenergic Receptor Agonists Termed sympathomimetic drugs Divided into three groups Direct-acting agonists –Catecholamines –Noncatecholamines Indirect-acting.
AUTONOMICS MA. JANETTH B. SERRANO, M.D. DPBA. Site and Mode of Action: Site and Mode of Action: 1. Direct Acting –Epinephrine- Dobutamine –Phenylephrine-
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
Adrenoceptor antagonist drugs Pawitra Pulbutr M.Sc. In Pharm (Pharmacology) Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Actions of epinephrine:
Lecture 11b Clinical uses of adrenergic agonists.
Lecture 7 Summary –Adrenalin (α & β): ↑ systolic BP & slight ↓diastolic BP –NA: (α & β1) ↑ systolic & diastolic BP + Reflex bradycardia –Isoproterenol.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Sympathetic Nervous System.
Adrenergic agonists Saja Hamed, Ph.D.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF ANS part 2 General Pharmacology M212.
Adrenergic Antagonists
17 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، 16.
PHARMACOLOGY OFADRENERGICS
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
Drug action on Sympathetic Nerves: No. 3: Sympatholytic drugs
SYMPATHOMIMETIC AGENTS
Adrenergic Agonists.
Adrenergic Antagonists (Sympatholytics). Basic stages in synaptic transmission.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
1 Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 17 & 18 Adrenergic Agonists & Antagonists.
Adrenergic Antagonists
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Adrenergic agonist: PHARMACOLOGY OF SNS.
Sympatholytic & adrenergic blockers -receptor Antagonists
Pharmacology of the nervous system
Adrenergic drugs.
Pharmacological actions of cathecholamines
β – ADRENERGIC BLOCKERS
Adrenergic Pharmacology
Adrenergic agonists.
Beta-adrenergic blocking agents
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Adrenergic agonists and antagonists
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic agonists ILOS
Adrenergic Antagonist
Adrenergic Antagonists
Adrenergic Agonists.
Chaper 20 Adrenoceptor Antagonists
Presentation transcript:

AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi

ADRENERGIC AGONIST DIRECT ACTING ADRENERGIC AGONIST: 1. Epinepherine: Synthesized in the adrenal medulla. At low doses has β vasodilatation effect. At high doses has α vasoconstriction effect. Action: 1. CVS: β1 +ve inotropic & chronotropic effect, COP & O2 demand. 2. Renal: β1 Renin release, blood flow is decreased.

3. Blood vessels: α1 constrict arterioles to skin, mucous membranes & viscera. β 2 dilate vessels to liver & muscles. 4. Respiratory: β2 bronchodilataion. 5. Hyperglycemia: β2 increases glycogenolysis & glucagon secretion. α2 decrease release of insulin. 6. Lipolysis.

P.kinetics: Rapid onset & short duration of action. Metabolized by MAO & COMT into metanephrine & venillymandilic acid. i.m, i.v, s.c, inhalation & endotracheal.

Therapeutic uses: Emergency bronchospasm.choice Anaphylactic shock.choice Cardiac arrest. Anesthesia. Control bleeding from mucous membranes. A.E: CNS disturbances. Hemorrage. Cardiac arrythmia. Pulmonary oedema.

NOREPINEPHERINE: Is the neurotransmiter. Therapeuticaaly has α activity. action: 1. CVS: 1. Vasoconistriction. 2. Baroreceptor reflex. 2. If atropin is given first it inhibits the vagus so N.e causes tachycardia. P.kinetics: i.v, poor s.c absorption, short duration of action.

Therapeutic uses: Only in shock. A.E: as epi.+ extravasation. ISOPROTERENOL: β receptors. Action: 1. CVS: Heart: +ve ino & chronotrpic effect. Peripheral vasodilation β2, slight increase in SBP due to action on heart.

2. pulmonary stopped, metabolic action. Used in cardiac arrest. A.E: as epi. DOPAMINE: High doses α1 Low doses β1 D1, D2 in mesenteric & renal vascular bed vasodilation.

Action: 1. CVS: +ve inotropic & chronotropic effect, vasoconistriction. 2. Renal & splanhinic vasodilatation. Therapeutic uses: In cardiogenic & septic shock, hypotension, severe CCF with oliguria. Metabolized by MAO & COMT to homovanillic acid. A.E as sympathetic stimulation.

Dobutamine: Selective β1 agonist used to COP in CCF & inotropic support after cardiac surgery. Phenylepherine: α1 agonist, rasis the BP, reflex bradycardia. Used topically as nasal decongestant & for ocular mydriasis. Used in SVT. A.E hypertensive headache & arrythmias.

Albuterol & terbutaline: Short acting β2 agonist, used as bronchodilators. A.E tremor, interaction with MAOIs. Salmeterol & formoterol: Long acting β2 agonist. Used with steroid mainly for nocturnal asthma.

INDIRECT ACTING ADRENERGIC AGONISTS Enhances the release of epi. Presynaptically or inhibit the uptake. AMPHETAMINE: Acts on α1 so BP. On β stimulates the heart. Note ADHS, appetite control, narcolepsy. TYRAMINE: Normal byproduct of tyrosine. Oxidized by MAOI in the gut. COCAINE: Inhibits the reuptake. α1 β effects.

MIXED ACTION ADRENERGIC AGONIST EPHEDRINE & PSEUDOEPHEDRINE: Long duration of action (poor COMT & MAO substrates). Ephedrine increases BP by systoilc & diastolic BP & cardiac stimulation. CNS stimualtion. atheletic performance. Pseudoehedrine:nasal,sinus decongestion.

ADRENER α GIC ANTAGONIST α ADRENERGIC BLOCKING AGENT Mainly affecting the BP. Reflex tachycardia. Phenoxybenzamine: Acts on α1 & α2 receptors. peripheral resistance, reflex tachycardia, COP & restore the decrease in BP. Obsolete in hypertension management. It’s an epinephrine reversal. Used in pheochromocytoma, Raynaud disease.

A.E: nasal stiffness, hypotension. Contraindicated in patients with coronary perfusion. PHENTOLAMINE: Action as phenoxybenzamine. Used for short treatment of pheochromocytoma. Norepinephrine administration. Hypertensive crisis with clonidine & tyramine- MAOI.

Selective α1 inhibitors prazosin, doxazosin, tamsulosin. Used for: HTN, CCF, BPH. A.E: nasal congestion, headache, orthostatic hypotension.

Β-adrenergic blocking agent All are competitive antagonist. Act on both β1 & β2 or are selective β1. Non-selective antagonists: Propranolol: CVS: COP, work, O2 consumption. Blocks β2 peripheral vasodilatation (no postural hypotension). Bronchoconstriction. Hypoglycemia.

P.K: First-pass effect, Cross BBB. Uses: 1. HTN. 2. Hyperthyroidism. 3. Angina pectoris. 4. M.I. A.E: bronchoconstriction, arrythmias, drug interactions. Timolol in chronic open-angle glucoma.

Selective antagonist β1 Atenolol, metoprolol, bisoprolol. HTN, diabetes, asthma. Antagonist with partial agonist activity: E.g pindolol & acebutolol. Hypertensive with moderate bradycardia, DM. Antagonist of both α & β arenoreceptors: Labetalol, carvedilol. Produce peripheral vasodilatation. HTN, PIH, HF.

Drugs affecting neurotransmitter release or uptake resrpine: move dopamine, serotonin & NE into the vesicles. Guanethidine: displaces NE from the vesicles. Cocaine: inhibits reuptake.

Thank you